The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 15, 2019
Filed:
Dec. 01, 2016
Applicant:
Ironshore Pharmaceuticals & Development, Inc., Camana Bay, KY;
Inventors:
David Lickrish, Camana Bay, KY;
Feng Zhang, Pflugerville, TX (US);
Assignee:
IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC., Camana Bay, KY;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 9/50 (2006.01); A61K 9/00 (2006.01); A61K 9/28 (2006.01); A61K 31/4458 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2866 (2013.01); A61K 9/0053 (2013.01); A61K 9/4808 (2013.01); A61K 9/5015 (2013.01); A61K 9/5026 (2013.01); A61K 9/5042 (2013.01); A61K 9/5047 (2013.01); A61K 9/5073 (2013.01); A61K 9/5084 (2013.01); A61K 31/137 (2013.01); A61K 31/4458 (2013.01); A61K 9/5078 (2013.01);
Abstract
Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) and other CNS stimulant responsive conditions include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 5 to 8 hours or longer, followed by an extended release.